Postmenopausal osteoporosis and estrogens

References

• Albright F, Bloomberg, & Smith PH. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940: 55: 305
   Google Scholar
• Garn SM. The earlier gain and later loss of cortical bone in nutritional perspective. Springfield. IL: CC Thomas. 1970
   Google Scholar
• Cameron JR, Mazess RB, Sorenson JA. Precision and accuracy of bone mineral determination by direct photon absorptiometry. Invest Radiol 1968: 3 (May-Jun): 141–50
   PubMedGoogle Scholar
• Krolner B, Pors Nielsen S. Measurement of bone mineral content (BMC) of the lumbar spine. I. Theory and application of a new two-dimensional dual-photon attenuation method. Scand J Clin Lab Invest 1980: 40(7): 653–63
   PubMed Web of Science ®Google Scholar
• Cann CE, Genant HK. Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr 1980: 4(4): 493–500
   PubMed Web of Science ®Google Scholar
• Saville PD. Changes in bone mass with age and alcoholism. J Bone Joint Surg 1965: 47(Apr): 492–9
   PubMedGoogle Scholar
• Aitken JM, Hart DM, Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J 1973: 3(Sep): 515–8
   PubMedGoogle Scholar
• Meema HE, Meema S. Prevention of postmenopausal osteoporosis by hormone treatment of the menopause. Can Med Assoc J 1968: 99(Aug): 248–51
   PubMedGoogle Scholar
• Heaney RP. Unified concept of the pathogenesis of osteoporosis: updated. In: Proceedings of the Tenth Steenbock Symposium on Osteoporosis. (In press)
   Google Scholar
• Heaney RP, Recker RR, Saville PD. Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr 1977: 30(10): 1603–11
   PubMed Web of Science ®Google Scholar
• Recker RR, Saville PD, Heaney RP. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977: 87(6): 649–55
   PubMed Web of Science ®Google Scholar
• Genant HK, Cann CE, Ettinger B, et al. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982: 97(5): 699–705
   PubMed Web of Science ®Google Scholar
• Christiansen C, Christensen MS, Larsen NE. et al. Pathophysiological mechanisms of estrogen effect on bone metabolism: dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab 1982: 55(6): 1124–30
   PubMed Web of Science ®Google Scholar
• Horsman A, Jones M, Francis R, et al. The effect of estrogen dose on post menopausal bone loss. N Engl J Med 1983: 309(23): 1406–7
   Web of Science ®Google Scholar
• Lindsay R. Hart DM, Forrest C, et al. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980: 2(8205): 1151–4
   PubMed Web of Science ®Google Scholar
• Weiss NS, Ure CL, Ballard JH, et al. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980: 303 (21): 1195–8
   PubMed Web of Science ®Google Scholar
• Antunes CM, Strolley PD, Rosenshein NB, et al. Endometrial cancer and estrogen use: report of a large case control study. N Engl J Med 1979: 300(1): 9–13
   PubMed Web of Science ®Google Scholar
• Collins J, Allen LH, Donner A, et al. Oestrogen use and survival in endometrial cancer. Lancet 1980: 2(8201): 961–4
   PubMed Web of Science ®Google Scholar
• Hammond CB, Jelovsek FR, Lee KL, et al. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 1979: 133(5): 537–47
   PubMed Web of Science ®Google Scholar
• Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979: 300(5): 218–22
   PubMed Web of Science ®Google Scholar
• Smith DC, Prentice R, Thompson DJ, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975: 293(23): 1164–7
   PubMed Web of Science ®Google Scholar
• Stern MP, Brown BW Jr, Haskell WL, et al. Cardiovascular risk and use of estrogens or estrogen-progestagen combinations: Stanford three-community study. JAMA 1976: 235(8): 811–5
   PubMed Web of Science ®Google Scholar
• Exton-Smith AN, Hodkinson HM, Stanton BR. Nutrition and metabolic bone disease in old age. Lancet 1966: 2(Nov): 999–1001
   PubMedGoogle Scholar
• Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981: 1(8218): 459–61
   PubMed Web of Science ®Google Scholar
• Committee of Principal Investigators. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Lancet 1980: 2(8191): 379–85
   PubMed Web of Science ®Google Scholar
• Saville PD, Nilsson BE. Height and weight in symptomatic postmenopausal osteoporosis. Clin Orthop 1966: 45(Mar-Apr): 49–54
   PubMedGoogle Scholar
• Daniell HW. Osteoporosis of the slender smoker: vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med 1976: 136(3): 298–304
   PubMedGoogle Scholar
• Saville PD, Kharmosh O. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum 1967: 10(Oct): 423–30
   PubMed Web of Science ®Google Scholar
• Avioli LV. Osteoporosis: pathogenesis and therapy. In: Avioli LV, Krane SM, eds. Metabolic bone disease. New York: Academic Press. 1977: 307–85
   Google Scholar
• Aitken JM. The prevention of osteoporosis. In: Heath DA Marx SJ, eds. Butterworth's international medical reviews: clinical endocrinology. Vol 2. London: Butterworth. 1982: 47–68
   Google Scholar
• Matkovic V, Kostial K, Simonovic I, et al. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 1979: 32(3): 540–9
   PubMed Web of Science ®Google Scholar